Diebold Nixdorf (DBD) Misses Q1 EPS by 92c
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $82.31 -2.2%
EPS Growth %: +30.9%
Financial Fact:
Total operating expense: 144.8M
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: +30.9%
Financial Fact:
Total operating expense: 144.8M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q1 EPS of ($0.85), $0.92 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $858.1 million versus the consensus estimate of $896.04 million.
GUIDANCE:
Diebold Nixdorf sees FY2023 revenue of $3.7-3.9 billion, versus the consensus of $3.82 billion. Sees adjusted Ebitda between $380-420M
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
- ADNOC Distribution agrees to buy Shell's South Africa unit for $1B
- Akari Therapeutics adds oncology expert Patricia LoRusso to advisory board
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
